Percutaneous radiofrequency ablation of ovarian cancer metastasis in the spleen: a therapeutic option to consider

Splenic metastasis are rare clinical entities developing in less than 1% of all metastatic cancers and usually in the setting of disseminated disease. To date, splenectomy is traditionally the first line therapy in patient with splenic metastasis, however non-surgical therapies have been reported. H...

Full description

Saved in:
Bibliographic Details
Published inJournal of ultrasound
Main Authors Boccatonda, Andrea, Mauloni, Paula Antonia, Cevenini, Monica, Masi, Livia, Bakken, Sofia Maria, Serra, Carla
Format Journal Article
LanguageEnglish
Published Italy 20.06.2024
Subjects
Spleen
Radiofrequency ablation
Thermal ablation
Metastasis
Ovarian cancer
Online AccessGet full text

Cover

More Information
Summary:Splenic metastasis are rare clinical entities developing in less than 1% of all metastatic cancers and usually in the setting of disseminated disease. To date, splenectomy is traditionally the first line therapy in patient with splenic metastasis, however non-surgical therapies have been reported. Here we described the case of a 57-year-old patient with splenic metastasis from ovarian cancer successfully treated by percutaneous radiofrequency ablation. Furthermore, we performed a literature systematic review of the cases of splenic metastases treated by thermal ablation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1876-7931
1876-7931
DOI:10.1007/s40477-024-00921-9